These data provide novel potential therapeutic targets, in agreement with recent work showing that novel theanine derivatives may have therapeutic applications in the treatment of lung cancers by targeting EGFR/VEGFR-Akt/NF-κB pathways [71]. Here, AKT1 is linked to lung carcinoma.